Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    17706760 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Is the WHO Recommended Dose of Pralidoxime Effective in the Treatment of Organophosphorus Poisoning?
Condition: Deaths
Intervention: Drug: Pralidoxime
2 Completed Adding Nebulized Salbutamol to Intravenous Atropine and Oxygen in OP Poisoning
Condition: Organophosphate Poisoning
Interventions: Drug: Standard care;   Drug: Standard care+ 2.5 mg Salbutamol;   Drug: Standard care+ 5 mg Salbutamol

Study has passed its completion date and status has not been verified in more than two years.